Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer
NCT02324101 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1100
Last updated 2014-12-24
Summary
Detect plasma Hsp90α concentration of breast cancer patients, healthy volunteers, benign breast diseases patients
Conditions
Interventions
- DEVICE
-
Hsp90
Detect plasma Hsp90α concentration
Sponsors & Collaborators
-
Protgen Ltd
lead INDUSTRY
Principal Investigators
-
Zhongsheng Tong, MD · Tianjin cance hospital
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-04-30
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- China
Study Locations
More Related Trials
-
A Multicenter Breast Cancer Biospecimen Registry
NCT02712645 ·Status: UNKNOWN
-
Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification
NCT01839045 ·Status: UNKNOWN
-
Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy
NCT01198301 ·Status: COMPLETED
-
A Study on Combined Low-pass Whole-genome and Methylome Testing of Bloody Nipple Discharge Specimens for Benign-Malignant Differentiation.
NCT07250204 ·Status: NOT_YET_RECRUITING
-
Prognosis and Targeted Therapy Related Molecular Screening Program for Patients of Breast Cancer in China
NCT03792529 ·Status: UNKNOWN
-
Clinical Application of ctDNA in Early Screening of Breast Cancer
NCT03973034 ·Status: UNKNOWN
-
Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
NCT05804578 ·Status: RECRUITING
-
The Treatment Situation of Chinese County Population With Breast Cancer
NCT05544123 ·Status: UNKNOWN
-
99mTc-3PRGD2 SPECT/CT in Breast Cancer Patients
NCT02742168 ·Status: COMPLETED ·Phase: NA
-
A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients
NCT00355316 ·Status: COMPLETED ·Phase: NA
-
PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST
NCT06979921 ·Status: ACTIVE_NOT_RECRUITING
-
Genetic and Protein Profiling in Normal and Cancerous Breast Tissue
NCT00083733 ·Status: COMPLETED
-
Retrospective Comparative in Vitro Case-controlled Study of the Liquid Biopsy Test System in Women With Breast Cancer
NCT04927130 ·Status: UNKNOWN
-
Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer
NCT00897416 ·Status: COMPLETED
-
99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast Cancer
NCT05622240 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients
NCT02669745 ·Status: COMPLETED
-
Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer
NCT05427617 ·Status: COMPLETED
-
A Prospective Longitudinal Breast Cancer Study
NCT02270931 ·Status: COMPLETED
-
Breast Cancer During Pregnancy
NCT02102282 ·Status: UNKNOWN
-
Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
NCT00813878 ·Status: TERMINATED
-
Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE)
NCT03252717 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
99mTc-ABH2 SPECT/CT in Breast Cancer
NCT06194565 ·Status: RECRUITING ·Phase: NA
-
Assessment of Candidate Protein Expression in Breast Cancer Specimens
NCT00918892 ·Status: COMPLETED
-
Breast Cancer Molecular Analysis Protocol
NCT01855503 ·Status: COMPLETED
-
Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After Testing
NCT01992471 ·Status: COMPLETED